For instance, Hong and colleagues (121) set up a cell-free tumor vaccine using tumor-derived exosomes carrying tumor associated antigens but had to deplete the exosomes of TGF-β1 to avoid the immunosuppressive effect. The gene discussed is TGFB1; the disease is neoplasm.